(Q38015901)

27 August 2017

title

Clinical translation of folate receptor-targeted therapeutics (English)

1 reference

27 August 2017

1 reference

Lesheng Teng

1

1 reference

27 August 2017

Jing Xie

series ordinal

2

1 reference

27 August 2017

Lirong Teng

series ordinal

3

1 reference

27 August 2017

Robert J Lee

series ordinal

4

1 reference

27 August 2017

language of work or name

English

0 references

publication date

5 June 2012

1 reference

Expert Opinion on Drug Delivery

27 August 2017

published in

1 reference

27 August 2017

volume

9

1 reference

27 August 2017

issue

8

1 reference

27 August 2017

page(s)

901-908

1 reference

Distribution, functionality and gene regulation of folate receptor isoforms: implications in targeted therapy

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.694863

Human reduced folate carrier: translation of basic biology to cancer etiology and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.694863

Expression cloning of a human cDNA encoding folylpoly(gamma-glutamate) synthetase and determination of its primary structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.694863

A review of folate receptor alpha cycling and 5-methyltetrahydrofolate accumulation with an emphasis on cell models in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.694863

Folate-targeted therapeutic and imaging agents for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.694863

The folate receptor: what does it promise in tissue-targeted therapeutics?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.694863

Folate-Targeted Therapies for Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.694863

Overexpression of folate binding protein in ovarian cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.694863

Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.694863

Rationale for folate receptor alpha targeted therapy in "high risk" endometrial carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.694863

The alpha folate receptor is highly activated in malignant pleural mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.694863

Folate receptor overexpression is associated with poor outcome in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.694863

Folate receptor alpha as a tumor target in epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.694863

Expression status of folate receptor alpha is significantly correlated with prognosis in non-small-cell lung cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.694863

Folate receptor type beta is a neutrophilic lineage marker and is differentially expressed in myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.694863

Folate receptor beta is expressed by tumor-associated macrophages and constitutes a marker for M2 anti-inflammatory/regulatory macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.694863

Folate receptor beta as a potential delivery route for novel folate antagonists to macrophages in the synovial tissue of rheumatoid arthritis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.694863

Folate receptor-mediated targeting of therapeutic and imaging agents to activated macrophages in rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.694863

Exploitation of the folate receptor in the management of cancer and inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.694863

Strategy for the treatment of acute myelogenous leukemia based on folate receptor beta-targeted liposomal doxorubicin combined with receptor induction using all-trans retinoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.694863

Characterization of human ovarian carcinoma-associated antigens defined by novel monoclonal antibodies with tumor-restricted specificity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.694863

Farletuzumab, a humanized monoclonal antibody against folate receptor alpha, in epithelial ovarian cancer: a phase I study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.694863

Farletuzumab in epithelial ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.694863

Preclinical radioimmunotargeting of folate receptor alpha using the monoclonal antibody conjugate DOTA-MORAb-003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.694863

Differential survival following trastuzumab treatment based on quantitative HER2 expression and HER2 homodimers in a clinic-based cohort of patients with metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.694863

Folate-conjugated methoxy poly(ethylene glycol)/poly(epsilon-caprolactone) amphiphilic block copolymeric micelles for tumor-targeted drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.694863

Folate-targeted, anionic liposome-entrapped polylysine-condensed DNA for tumor cell-specific gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.694863

Folate-immunoglobulin G as an anticancer therapeutic antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.694863

Targeting T cells against brain tumors with a bispecific ligand-antibody conjugate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.694863

A conjugate of a tumor-targeting ligand and a T cell costimulatory antibody to treat brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.694863

Design, synthesis, and biological functionality of a dendrimer-based modular drug delivery platform

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.694863

Folate receptor-targeted immunotherapy of cancer: mechanism and therapeutic potential.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.694863

Exploratory study of 99mTc-EC20 imaging for identifying patients with folate receptor-positive solid tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.694863

Folate receptor-specific antitumor activity of EC131, a folate-maytansinoid conjugate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.694863

Folate-targeted PEG as a potential carrier for carboplatin analogs. Synthesis and in vitro studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.694863

Synthesis and evaluation of taxol-folic acid conjugates as targeted antineoplastics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.694863

In vivo structural activity and optimization studies of folate-tubulysin conjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.694863

Preclinical evaluation of EC145, a folate-vinca alkaloid conjugate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.694863

EC145: a novel targeted agent for adenocarcinoma of the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.694863

Folate supplementation: too much of a good thing?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.694863

10.1517/17425247.2012.694863

21 January 2018

Identifiers

DOI

1 reference

27 August 2017

1 reference